---
schema_version: "secwatch.filing_event.v1"
accession: "0001104659-23-093669"
form_type: "8-K"
ticker: null
cik: "0001178879"
company_name: "AMICUS THERAPEUTICS, INC."
filed_at: "2023-08-21T23:59:59+00:00"
generated_at: "2026-06-11T05:59:20.232133+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.6
calibrated_materiality_score: 0.6
confidence: "high"
source: SEC EDGAR
---

# Amicus Therapeutics Appoints Simon Harford as CFO; Daphne Quimi to Retire by Year End

## Summary
- Simon Harford appointed CFO effective August 21, 2023; replaces Daphne Quimi who will retire at year end.
- Harford receives base salary $500,000, bonus target 45% of salary, and initial equity award valued at $2.7M.
- Company reiterates expectation to achieve profitability in second half of 2023.
- Harford previously served as CFO of Albireo Pharma and Parexel; 30+ years healthcare finance experience.

## SEC filing metadata
- accession: 0001104659-23-093669
- form_type: 8-K
- cik: 0001178879
- company_name: AMICUS THERAPEUTICS, INC.
- filed_at: 2023-08-21T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.6
- calibrated_materiality_score: 0.6
- confidence: high
- sec_items: 5.02, 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1178879/000110465923093669/0001104659-23-093669-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1178879/000110465923093669/tm2324228d1_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001104659-23-093669
- JSON: https://secwatch.observer/filing/0001104659-23-093669.json
- Plain text: https://secwatch.observer/filing/0001104659-23-093669.txt

## Key facts
- Executive change
  Simon Harford was appointed as Chief Financial Officer at AMICUS THERAPEUTICS, INC..
  - Action: appointed
  - Role: Chief Financial Officer
  source text: appointed Simon Harford as the Chief Financial Officer (principal financial officer) of the Company, effective as of August 21, 2023.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1178879/000110465923093669/0001104659-23-093669-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.